Akoya Biosciences unveils strategic product roadmap, powered by the new IO60 and upcoming neurobiology panels
The new offerings solidify leadership in spatial biology and broaden reach to new verticals
The new offerings solidify leadership in spatial biology and broaden reach to new verticals
The new platform has been designed to enable faster analysis of PhenoCycler-Fusion data
Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers
Innovations include a novel spatial transcriptomics chemistry and universal protein chemistry for accelerated biomarker discovery and validation
The partnership pairs Akoya’s spatial phenotyping solutions and PathAI’s AI-based algorithms to elucidate spatial biomarker signatures for biopharma partners
Collaboration aims to provide new workflows, faster acquisition speeds and deeper resolution
For the first time Astronomy and Pathology (AstroPath™) come together to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence
The Proxima spatial analysis software solution integrates image acquisition to data analysis in the secure cloud for rapid access by any user
University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery
Akoya Biosciences determines that multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies